By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Huapont Life Sciences Co., Ltd. (002004.SZ)

SHZ Currency in CNY
¥4.93
+¥0.06
+1.23%
Last Update: 29 Aug 2025, 07:04
¥9.73B
Market Cap
15.30
P/E Ratio (TTM)
Forward Dividend Yield
¥3.74 - ¥5.23
52 Week Range

002004.SZ Stock Price Chart

Explore Huapont Life Sciences Co., Ltd. interactive price chart. Choose custom timeframes to analyze 002004.SZ price movements and trends.

002004.SZ Company Profile

Discover essential business fundamentals and corporate details for Huapont Life Sciences Co., Ltd. (002004.SZ) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

25 Jun 2004

Employees

12.58K

CEO

Hai An Zhang

Description

Huapont Life Sciences Co., Ltd. engages in the pharmaceutical and agrochemical businesses in China and internationally. The company is involved in the production and sale of pharmaceutical preparations and intermediates. It also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and ophthalmology, as well as health management products. In addition, the company provides pesticide technical, intermediate and preparation products, and GLP registration technical services. The company was formerly known as Huapont-Nutrichem Co., Ltd. and changed its name to Huapont Life Sciences Co., Ltd. in September 2015. Huapont Life Sciences Co., Ltd. was founded in 2001 and is based in Chongqing, China. Huapont Life Sciences Co., Ltd. was formerly a subsidiary of Huipont Tourism Co. Ltd.

002004.SZ Financial Timeline

Browse a chronological timeline of Huapont Life Sciences Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 23 May 2025

EPS came in at -¥0.38 , while revenue for the quarter reached ¥2.75B .

Earnings released on 31 Mar 2025

EPS came in at ¥0.09 , while revenue for the quarter reached ¥2.82B .

Earnings released on 29 Sept 2024

EPS came in at ¥0.07 , while revenue for the quarter reached ¥2.99B .

Earnings released on 30 Jun 2024

EPS came in at ¥0.08 , while revenue for the quarter reached ¥3.01B .

Dividend declared on 3 Jun 2024

A dividend of ¥0.22 per share was announced, adjusted to ¥0.22. The dividend was paid on 3 Jun 2024.

Earnings released on 23 May 2024

EPS came in at -¥0.10 , while revenue for the quarter reached ¥2.74B .

Earnings released on 31 Mar 2024

EPS came in at ¥0.08 , while revenue for the quarter reached ¥2.92B .

Earnings released on 30 Sept 2023

EPS came in at ¥0.06 , while revenue for the quarter reached ¥2.98B .

Earnings released on 30 Jun 2023

EPS came in at ¥0.11 , while revenue for the quarter reached ¥2.89B .

Dividend declared on 15 Jun 2023

A dividend of ¥0.22 per share was announced, adjusted to ¥0.22. The dividend was paid on 15 Jun 2023.

Earnings released on 31 Mar 2023

EPS came in at ¥0.15 , while revenue for the quarter reached ¥2.98B .

Earnings released on 1 Jan 2023

EPS came in at -¥0.14 , while revenue for the quarter reached ¥3.05B .

Earnings released on 30 Sept 2022

EPS came in at ¥0.19 , while revenue for the quarter reached ¥3.48B .

Earnings released on 30 Jun 2022

EPS came in at ¥0.32 , while revenue for the quarter reached ¥3.30B .

Dividend declared on 2 Jun 2022

A dividend of ¥0.22 per share was announced, adjusted to ¥0.22. The dividend was paid on 2 Jun 2022.

Earnings released on 29 Apr 2022

EPS came in at ¥0.10 , while revenue for the quarter reached ¥3.73B .

Earnings released on 31 Mar 2022

EPS came in at ¥0.16 , while revenue for the quarter reached ¥3.40B .

Earnings released on 1 Nov 2021

EPS came in at ¥0.11 , while revenue for the quarter reached ¥2.93B .

Earnings released on 30 Sept 2021

EPS came in at ¥0.11 , while revenue for the quarter reached ¥2.88B .

Dividend declared on 30 Apr 2021

A dividend of ¥0.22 per share was announced, adjusted to ¥0.22. The dividend was paid on 30 Apr 2021.

Earnings released on 31 Mar 2021

EPS came in at ¥0.06 , while revenue for the quarter reached ¥2.82B .

Earnings released on 31 Dec 2020

EPS came in at ¥0.07 , while revenue for the quarter reached ¥2.99B .

Earnings released on 30 Sept 2020

EPS came in at ¥0.10 , while revenue for the quarter reached ¥2.71B .

002004.SZ Stock Performance

Access detailed 002004.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run